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Abstract
Objectives: To investigate the clinical characteristics and pre- biopsy provisional diagnoses of benign oral mucosal 
tumors.
Material and Methods: A 10- year retrospective analysis of all benign tumors of the oral mucosa, from a univer-
sity- affiliated oral and maxillofacial surgery department. 
Results:  146 benign tumors were included. The mean age was 49.6 years, with an approximately equal gender dis-
tribution. The most prevalent tumor types were lipomatous tumors (27.4%), vascular (23.3%), and salivary gland 
tumors (16.5%). Tongue, labial and buccal mucosa were the most frequently involved sites. The vast majority 
(98.6%) presented as non-ulcerated masses. Only 2 (1.4%) presented as ulcerated masses. The clinical provisional 
diagnosis correctly classified lesions as non-malignant in 93.3%. In only 9 (6.7%) suspicion of malignancy was in-
cluded in the provisional diagnosis. However, benign neoplasia was unsuspected in 42.1% of tumors. These cases 
were clinically classified as reactive.
Conclusions: Benign tumors were most likely to be clinically correctly classified as non-malignant, but even in the 
setting of experienced oral surgeons, neoplasia was unsuspected in more than 40% of cases. This data strongly 
supports the need to biopsy every oral mucosal mass, since inaccurate clinical evaluation of the lesion’s biological 
nature was a frequent event. 
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Introduction
The diagnosis of a wide range of lesions occurring in the 
oral mucosa is a vital part of dental practice. One of the 
main tools in developing a list of potential diagnosis for 
a lesion is knowledge of the frequency of each potential 
lesion type (1). This information can   provide clinicians 
with the data to predict the probability of its occurrence. 
Unfortunately, information from the literature relating 
to the frequency of oral benign mucosal tumors is un-
common. Studies relating to benign tumors of the oral 
mucosa have been published in the literature, focusing 
on clinico-pathologic correlations of lipoma variants 
(2-5), salivary gland tumors (6-9), hemangiomas (10-
12), neural (13-14) and other soft tissue mucosal tumors 
(15-21). Most of these do not relate directly to the clini-
cal appearance and rate of ulceration of the tumors but 
rather, describe oral mucosal benign tumors as swellings 
or raised lesions. None of these studies investigated the 
accuracy of the pre- biopsy clinical in comparison to the 
final diagnosis. In text books and large scale screening 
studies benign tumors are described as raised masses or 
swellings (22-25), but a comprehensive analysis focus-
ing on the spectrum of the benign oral mucosal tumors, 
including the clinical appearance and accuracy of the 
clinical differential diagnosis has not been found.
In a recently published 10-year retrospective analysis 
of malignant tumors of the oral mucosa, we found that 
close to 60% of oral malignancies presented as non-
ulcerated masses, 20% presented as ulcerated masses 
and 12% as indurated ulcers (26). This pointed out that 
within the study sample, non-ulcerated masses rather 
than indurate ulcers were the most common clinical 
presentations of oral mucosalmalignancies. Another 
unexpected finding was that approximately one third of 
the oral mucosal malignancies were not suspected to be 
malignant prior to biopsy. 
The aims of this study were to investigate the clinical 
characteristics and pre- biopsy provisional diagnoses of 
benign tumors of the oral mucosa. 
Material and Methods
The study was conducted as a 10- year retrospective 
analysis. For the present study the archives of the Insti-
tute of Pathology of the Rabin Medical Center, Patah-
Tikva, Israel were screened for benign tumors of the 
oral mucosa. The study included only diagnostic biop-
sies which were microscopically diagnosed as benign 
tumors, while those lacking information on clinical 
presentation were excluded. The pre-biopsy clinical 
differential diagnoses with which the biopsies were 
submitted were classified into reactive/ developmental 
lesions, benign tumors or malignancy, as previously de-
scribed (27). In cases that included more than a single 
provisional diagnosis, the analysis included the classi-
fication which was the most severe possibility. There-
fore, in cases that included a request to rule out a ma-
lignancy, the clinical diagnosis included in the analysis 
was of malignancy. Being a university-affiliated in-
stitution training residents for national boards in oral 
and maxillofacial surgery, high clinical standards are 
implemented for clinical examination and reporting in 
patients’ charts. All biopsies were performed by senior 
members of the department (GG, GC, DMA) with 9-35 
years of experience, or by residents closely supervised 
by them. The study was approved by the institutional 
review board. 
Results
During a 10-year period (2001-2011), a total of 146 be-
nign tumors of the oral mucosa met the inclusion crite-
ria (Fig. 1). There were 78 males and 68 females, rep-
resenting an approximately equal gender distribution 
(Table 1).
The most prevalent tumor types were lipomatous tu-
mors (27.4%), hemangioma variants (23.3%), and sali-
vary gland tumors (16.5%). Other groups included neu-
ral and granular cell tumors (9.6% each), fibroblastic/ 
myofibroblastic (7.6%), with the remaining classified 
as miscellaneous (Table 2). The age range was wide, (3 
months-86 years) with a mean age of 49.6 years. The 
mean age at diagnosis of the lipomatous and salivary 
gland tumors was higher than that of the neural and fi-
broblastic/myofibroblastic tumors (over 50 and below 
40 years, respectively) (Fig. 2).
The mobile tongue was the most frequently affected site 
(28.3%), followed by the labial mucosa (19.9%), buccal 
mucosa/vestibule (19.1%), hard palate (14.2%), gingiva/
alveolar ridge (13.5%) and floor of mouth (4.3%). The 
lesion’s size ranged between 2-40 mm, mean 10.5. 
The vast majority (98.6%) of the benign tumors in the 
oral mucosa presented as a non-ulcerated masses (Table 
3). Only 2 cases (1.4%) presented as ulcerated masses. 
These included one cavernous hemangioma of the lower 
lip in a 30 years old male and a granular cell tumor of the 
tongue in a 6 years old boy. The clinical description of 
ulceration was validated microscopically in both cases, 
and none of the cases in which ulceration had not been 
clinically described showed microscopic ulceration. 
In regard to the pre-biopsy provisional diagnoses, 126 
(93.3%) were correctly classified clinically as non-ma-
lignant, while only in 9 (6.7%) benign tumors arose sus-
picion for malignancy, (6.7% false negative) (Table 4). In 
73 (57.9%) cases, the provisional diagnoses of a benign 
tumor was correct, while in 53(42.1%) benign neoplasia 
was an unsuspected finding, these cases were consid-
ered reactive lesions in the provisional diagnosis.
 
Discussion
The objective of the present study was to provide a com-
prehensive view of the spectrum of benign tumors of the 
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oral mucosa. Lipomatous, vascular (hemangioma) and 
salivary gland tumors, in descending order, were the 
most prevalent in this series. The tongue, labial and buc-
cal mucosa were the most prevalent sites of presentation.
There seemed to be differences in the age distribution 
between tumor groups: while neural tumors and fibro-
blastic/myofibroblastic tumors had a mean age under 40 
years, lipomatous, vascular and salivary gland tumors 
presented a mean age between 54-63 years. However, 
there was a wide range with considerable overlap be-
tween the groups.
The size of benign tumors ranged between 2-40 mm in 
diameter for the entire study group. The salivary gland 
tumors presented the highest mean size (16.7 mm), while 
the vascular and fibroblastic/myofibroblastic tumors pre-
sented the lowest mean size (7 and 8.1 mm respectively).
Almost all the benign tumors included in the study pre-
sented as non- ulcerated masses. Only two presented 
as ulcerated masses and none as indurate ulcers or flat 
lesions. Most of the benign tumors were clinically clas-
sified correctly as non- malignant and did not raise any 
clinical suspicion for malignancy. However, more than 
forty percent of these benign tumors were clinically 
thought to be reactive, and did not raise suspicion of 
neoplasia. The results of the present series emphasize 
that the ulceration rate of benign oral mucosal tumors is 
very low, a feature  that up till the present was described 
only in sporadic reports such as an ulcerated canalicular 
Fig. 1. The incidence of benign tumor groups in the oral mucosa. 
Number of benign tumors 146 
Diagnoses (n=146) 
Lipomatous tumors 40 (27.4%) 
Vascular tumors 34 (23.3%) 
Salivary gland tumors 24 (16.5%) 
Neural tumors 14 (9.6%) 
Granular cell tumors 14 (9.6%) 
Fibroblastic/myofibroblastic lesions 11 (7.6%) 
Miscellaneous tumors 9 (6%) 
M:F 78:68 
Age range, (years) 0.25-86, mean 49.6 
Site (n= 141) 
Tongue 40 (28.3%) 
Labial mucosa 28 (19.9%)  
Buccal mucosa & vestibule 27 (19.1%) 
Hard palate 20 (14.2%) 
Gingiva/ridge/retromolar 19 (13.5%) 
Floor of mouth 6 (4.3%) 
Pterygomandibular raphe 1 (0.7%) 
Size range, (mm) 2-40,  mean 10.5 
Table 1. Benign tumors of the oral mucosa, clinical data. 
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Lipomatous tumors
Fibrolipoma 26 (65%) 
Lipoma 14 (35%) 
n= 40 (27.4%)  
M:F  22:18 (1.2:1)  
Age:  44-84(years), mean 62.8  
Size:  2-40 (mm), mean 10.5 
Site (n=37)  
Buccal mucosa & vestibule 14 (37.8%) 
Tongue 10 (27%) 
Gingiva/ridge/retromolar 7 (19%) 
Labial mucosa 6 (16.2%)  
Vascular tumors (hemangioma) n= 34 (23.3%)  
M:F  19:15  
Age: 8-86 (years), mean 54.6 
Size: 3-15 (mm), mean 7 
Tongue 12(35.3%) 
Lower lip 11(32.3%) 
Buccal mucosa 4 (11.8%) 
Alveolar ridge 4 (11.8%) 
Hard palate 2 (5.9%) 
Upper lip 1(2.9%) 
Salivary gland tumors
Pleomorphic adenoma 16 (66.7%)  
Cystadenoma 5(20.8%) 
Canalicular adenoma 2 (8.3%)  
Myoepithelioma 1(4.2%)
n=24 (16.5%) 
M:F  11:13  
Age: 12-85(years) , mean  56 
Size: 5-30 (mm), mean 16.9  
Palate 13(54.2%) 
Upper lip 4(16.7%) 
Buccal mucosa/vestibule 4 (16.7%)  
Retromolar 2(8.3%) 
Floor of mouth (4.1%) 
Neural tumors
Schwannoma 8 (57.2%) 
Neurofibroma 4 (28.6%) 
Multiple neuroma 1(7.1%) 
Peripheral nerve sheath tumor 
1(7.1%)
n=14 (9.6%)  
M:F  11: 3  
Age: 8-54(years), mean 32.9  
Size:  8-30(mm), mean 12.7  
Lower lip 4(28.6%) 
Gingiva 3(21.4%)  
Tongue 2(14.3%) 
Floor of mouth 2(14.3%) 
Buccal mucosa/ vestibule 2(14.3%) 
Hard palate 1(7.1%) 
Granular cell tumors n=14 (9.6%)  
M:F  5: 9 
Age: 6-77 (years),  mean 47.6 
Size: 5-35 (mm), mean 12.3  
Tongue 13 (92.9%) 
Floor of mouth 1 (7.1%) 
Fibroblastic/myofibroblastic 
tumors
Myofibroma 4(36.4%) 
Fibroma (true) 3(27.2%) 
Nodular fasciitis 2 (18.2%) 
Collagenous fibroma 1(9.1%) 
Solitary fibrous tumor 1(9.1%)
n=11(7.6%) 
M:F  7:4 
Age: 2-54 (years), mean 38.4   
Size: 3-30 (mm) , mean 8.1 
Palate: 3 (27.2%)  
Buccal mucosa 3 (27.2%) 
Floor of mouth 2 (18.3%)  
Pterygomandibular raphe 1(9.1%)  
Gingiva: 1(9.1%) 
 Lower lip: 1(9.1%) 
Miscellaneous tumors  
Leiomyoma 3 
Peripheral odontogenic fibroma 3 
Angiokeratoma 2 
Ectomesenchymal chondromyxoid 
tumor of tongue 1 
n=9 (6%) 
M:F 3:6 
Age: 3-82, mean 42.3 
Size: 7-30, mean 15.7 
Gingiva 4 
Tongue 3 
Lower lip 1 
Palate 1 
Table 2. Clinical characteristics of the tumor groups involving oral mucosa. 
Fig. 2. Mean age at diagnosis of benign tumors in the oral mucosa.
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adenoma from the palate (8-9) or an ulcerated myofi-
broblastic tumor (16). 
This study follows a previous study on malignancies of 
the oral mucosa (26). When comparing the results of 
the present study to those from the malignant oral mu-
cosal tumors, performed in the same center and same 
time period, it is evident that while in the benign tu-
mors 98% presented as non-ulcerated masses, in the 
malignant group there was a significantly higher frac-
tion presenting as ulcerated masses (20.4%) or indurate 
ulcers (11.9%), although still more than half (59.7%) of 
the malignancies were non- ulcerated at presentation 
(26). These differences were statistically significant 
(p<0.001, chi-square).
When considering the pre-biopsy classification as malig-
nant or non-malignant lesions (reactive, developmental 
or benign tumors), the accuracy was significantly high-
er in the benign tumor group (93.3%), compared with 
only 68.9% in the malignant tumor group. This implies 
a significantly higher fraction of false negatives in clini-
cal identification of malignancies (31.1% in the malig-
nant compared to 6.7% in benign groups,  p<0.001, chi-
square). Interestingly, the percent of unsuspected neo-
plasia in the benign tumors (42.1%), was quite similar to 
the percent of unsuspected malignancy in the malignant 
tumor group (31.1%). The data presented was obtained 
from a medical teaching center and even in this context 
of highly skilled clinicians, 31.1-42.1% of both malig-
nant and benign neoplasia where unsuspected as such 
prior to biopsy. This highlights the fact that the ability 
to recognize a neoplasm on a clinical basis is quite lim-
ited. Since non- ulcerated masses are the typical pre-
sentation of almost all benign mucosal tumors (present 
results), more than half of the malignant tumors (26) 
and the majority of reactive lesions (27), the ability to 
predict the true biological nature of oral mucosal mass-
es using visual inspection alone is relatively poor, thus, 
diagnostic biopsy stays an essential and mandatory tool 
for diagnosis of all masses of oral mucosa. Although 
the majority of mucosal masses would turn out to be 
reactive following microscopic analysis, they must not 
be ignored since both benign and malignant neoplasms 
cannot be differentiated clinically from reactive lesions 
with a high degree of confidence. In the decision wheth-
er a mass should be removed and submitted for analysis, 
or followed-up, the allusive “clinical judgment” should 
play a minimal role. There should be stronger emphasis 
on the need to biopsy every oral mass, regardless of its 
ulceration status. 
A few possible explanations to the different rate of ul-
ceration between benign and malignant tumors may be 
proposed: size-related, site- related and biological as-
pects. Regarding the size, it is possible that as lesions 
grow they interfere with anatomical structures, com-
promise the blood supply, or may become traumatized 
during functional movements such as mastication and 
speech and therefore ulcerate. However, there was a 
significant overlap in the size range between the be-
Ulcerated 
mass
Non-ulcerated 
massType of benign tumor
-40(100%)Lipomatous
1 (3%)33 (97%) Vascular
-24 (100%)Salivary gland
-14 (100%) Neural
1 (7.1%) 13 (92.9%) Granular cell
-11 (100%)Fibroblastic/myofibroblastic
-9 (100%)Miscellaneous
2(1.4%) 144 (98.6%) Total benign tumors (n=146)
Table 3. The frequency of ulceration in benign tumors.
Clinical Differential DiagnosisFinal Diagnosi Non-malignantMalignant
38(100%)-Lipomatous tumors
32(97%)1(3%)Vascular tumors 
19(95%)1(5%)Salivary gland tumors
11(78.6%) 3(21.4%) Neural tumors
12(92.3%)1(7.7%)Granular cell tumors
8(80%)2(20%)Fibroblastic/myofibroblastic tumors
6(85.7%)1(14.3%)Miscellaneous tumors
126(93.3%)9(6.7%)Total (n=135)
Table 4. The accuracy of provisional clinical diagnosis, classification as benign or 
malignant. 
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nign and malignant groups (2-40 mm versus 5-30 mm 
respectively), therefore, size alone would not be a con-
tributing factor for ulceration.
Regarding the site, it is possible that lesions appearing 
in specific sites may be easily traumatized. However, 
the tongue was the most common site for both malignant 
(26) and benign tumors (present study), so it appears 
that the site distribution cannot offer an adequate ex-
planation for the difference in the clinical presentation. 
Therefore, additional contributing factors related to the 
different biological characteristics of the tumors may 
possibly account for the differences. Within the group 
of malignancies, there were also differences between 
the tumor types in the tendency to become ulcerated: 
SCC ulcerated more frequently than other tumor types, 
supporting the assumption that differences probably re-
sult from variations in biological characteristics (26).
In conclusion, the clinical ability to recognize benign 
mucosal neoplasms by visual inspection is relatively 
poor. In about 40% of the benign mucosal tumors, neo-
plasia was clinically unsuspected, thus, the need to bi-
opsy every oral mucosal mass is supported. 
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